Search Results
424 items found for "Chemokine receptor"
- 📰 GPCR Weekly News, February 13 to 19, 2023
Reviews, GPCRs, and more Single nucleotide variations encoding missense mutations in G protein-coupled receptors GPCR Function Quantitative analysis of sterol-modulated monomer-dimer equilibrium of the β1-adrenergic receptor OLINVYK Respiratory Physiology Study In Anesthesiology Neurocrine Biosciences discovers new muscarinic M4 receptor
- 📰 GPCR Weekly News, February 6 to 12, 2023
Methods & Updates in GPCR Research Engineered Human Antibody with Improved Endothelin Receptor Type A Development and Characterization of a Highly Selective Turn-On Fluorescent Ligand for β3-Adrenergic Receptor Quantitative analysis of sterol-modulated monomer-dimer equilibrium of the β1-adrenergic receptor by
- A new Kunitz-type snake toxin family associated with an original mode of interaction with the...
Kunitz-type snake toxin family associated with an original mode of interaction with the vasopressin 2 receptor from the Dendroaspis angusticeps venom is the most selective antagonist of the arginine-vasopressin V2 receptor
- GPCR/endocytosis/ERK signaling/S2R is involved in the regulation of the internalization...
We investigated the influence of specific inhibitors of G protein-coupled receptors (GPCR), endocytosis We performed a siRNA knockdown (KD) to assess the effect of Sigma-2 receptor (S2R) /Transmembrane Protein
- Ono Enters into Collaboration Agreement with Domain Therapeutics and Université de Montréal for ...
de Montréal (Québec, Canada; “UdM”), to discover novel small molecules targeting G-Protein Coupled Receptors
- Confo Therapeutics receives €1.7 million VLAIO grant for further research on GPCR modulators for ...
The grant should help expand Confo Therapeutic ’s research on G protein-coupled receptor (GPCR) drug
- SYnAbs is now officially accredited as a Research Tax Credit by the French Ministry of Higher...
trust us in the generation of their monoclonal antibodies against small molecules and transmembrane receptors
- Tectonic Therapeutic Strengthens Leadership Team
biotechnology company transforming the discovery of novel GPCR-targeted therapies (G-Protein Coupled Receptors
- Chemogenetic stimulation of the G i pathway in astrocytes suppresses neuroinflammation
Engineered G protein-coupled receptors (GPCRs) are commonly used in chemogenetics as designer receptors
- GPCRS: AN ODYSSEY FROM STRUCTURE, SIGNALING AND REGULATION TO THERAPEUTICS
APRIL 06 - 09, 2022 | | SNOWBIRD RESORT, UTAH, UNITED STATES The superfamily of G protein-coupled receptors molecular mechanisms of GPCR function has revealed new paradigms with increasingly complex models of receptor
- Modulation of Striatal Adenosinergic Function by HTL0041178, a Selective GPR52 Agonist
novel GPR52 agonist HTL00411718 to modulate centrally mediated locomotor activity in response to A2A receptor
- GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma
September 2022 "Background G protein-coupled receptor (GPCR) is the most targeted protein family by
- Verily links up with Sosei Heptares for GPCR drug discovery
January 2022 "G-protein-coupled receptors’ star has been on the rise in biotech in recent years as researchers
- Septerna emerges with $100M to spark 'second golden age' of prolific drug target GPCR with ...
co-founder "J an 27, 2022 07:00am Septerna wants to spark a second golden age in G-protein-coupled receptor
- Emerging approaches for decoding neuropeptide transmission
post-translational processing, release from dense core vesicles, and ability to activate G-protein-coupled receptors
- Trevena Announces Advancement of TRV045 Into Clinical Development for Diabetic Neuropathic Pain
TRV045 is the Company’s novel S1P1 receptor modulator being developed as a potential treatment for diabetic
- Domain Therapeutics Raises $42m Series A Financing
company specializing in the research and development of innovative drugs targeting G Protein-Coupled Receptors
- GPCR Therapeutics Expands Scientific Advisory Board
biopharmaceutical company with an innovative approach to drug discovery based on targeting G Protein Coupled Receptors
- High hedgehog signaling is transduced by a multikinase-dependent switch controlling the...
switch controlling the apico-basal distribution of the GPCR smoothened "The oncogenic G-protein-coupled receptor
- Addex Therapeutics Completes Patient Enrollment For Dipraglurant Blepharospasm Phase 2 Clinical ...
Dipraglurant selectively targets the metabotropic glutamate receptor subtype 5 (mGlu5) through allosteric
- Search for safer pain relief advances with new engineered compounds
pain-relieving compounds that, like morphine and other drugs, provide relief via activation of opioid receptors
- Label-free LC-MS based assay to characterize small molecule compound binding to cells
In one example, to study a G protein coupled receptor (GPCR), we used one antagonist as probe and multiple
- Domain Therapeutics and Explicyte enter partnership agreement in immuno-oncology
biopharmaceutical company specializing in the discovery and development of new drugs targeting G Protein-Coupled Receptors
- Addex Expands Pipeline With Selective M4 Positive Allosteric Modulator Program For The Treatment ...
drug discovery and development, announced today that it has moved a selective and potent M4 muscarinic receptor
- Finding needles in haystacks: Omass unveils pipeline aimed at tough-to-drug targets
The targets, including G protein-coupled receptors (GPCRs), intracellular protein complexes and solute
- California gold rush for Sosei Heptares
The vision is to develop novel muscarinic receptor agonists for schizophrenia and other neuropsychiatric
- Cholesterol occupies the lipid translocation pathway to block phospholipid scrambling by a GPCR
September 2022 "Class A (rhodopsin-like) G protein-coupled receptors (GPCRs) are constitutive phospholipid
- C3aR plays both sides in regulating resistance to bacterial infections
results in the production of bioactive C3a, a product of C3 cleavage, which interacts with membrane-bound receptor